ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/01/17 | 1,186 | 1,191 | 1,142 | 1,147 | -41 | -3.5% | 205,800 |
| 2022/01/14 | 1,205 | 1,213 | 1,180 | 1,188 | -43 | -3.5% | 446,400 |
| 2022/01/13 | 1,271 | 1,294 | 1,231 | 1,231 | -70 | -5.4% | 220,200 |
| 2022/01/12 | 1,270 | 1,302 | 1,261 | 1,301 | +58 | +4.7% | 142,800 |
| 2022/01/11 | 1,201 | 1,251 | 1,195 | 1,243 | +33 | +2.7% | 276,800 |
| 2022/01/07 | 1,201 | 1,220 | 1,194 | 1,210 | +8 | +0.7% | 206,600 |
| 2022/01/06 | 1,239 | 1,272 | 1,193 | 1,202 | -67 | -5.3% | 355,500 |
| 2022/01/05 | 1,254 | 1,275 | 1,234 | 1,269 | +1 | +0.1% | 176,000 |
| 2022/01/04 | 1,281 | 1,281 | 1,235 | 1,268 | -15 | -1.2% | 213,500 |
| 2021/12/30 | 1,330 | 1,330 | 1,283 | 1,283 | -52 | -3.9% | 309,000 |
| 2021/12/29 | 1,309 | 1,355 | 1,309 | 1,335 | +22 | +1.7% | 168,800 |
| 2021/12/28 | 1,327 | 1,338 | 1,287 | 1,313 | +1 | +0.1% | 212,100 |
| 2021/12/27 | 1,351 | 1,351 | 1,290 | 1,312 | -53 | -3.9% | 237,200 |
| 2021/12/24 | 1,334 | 1,381 | 1,323 | 1,365 | +41 | +3.1% | 214,700 |
| 2021/12/23 | 1,377 | 1,383 | 1,311 | 1,324 | -33 | -2.4% | 280,700 |
| 2021/12/22 | 1,319 | 1,375 | 1,311 | 1,357 | +66 | +5.1% | 329,500 |
| 2021/12/21 | 1,301 | 1,306 | 1,255 | 1,291 | +9 | +0.7% | 301,100 |
| 2021/12/20 | 1,240 | 1,314 | 1,240 | 1,282 | +54 | +4.4% | 420,500 |
| 2021/12/17 | 1,278 | 1,303 | 1,211 | 1,228 | -76 | -5.8% | 440,000 |
| 2021/12/16 | 1,276 | 1,311 | 1,276 | 1,304 | +58 | +4.7% | 235,100 |
| 2021/12/15 | 1,235 | 1,255 | 1,205 | 1,246 | +2 | +0.2% | 146,500 |
| 2021/12/14 | 1,229 | 1,277 | 1,225 | 1,244 | +24 | +2% | 247,900 |
| 2021/12/13 | 1,228 | 1,236 | 1,185 | 1,220 | -12 | -1% | 236,100 |
| 2021/12/10 | 1,267 | 1,270 | 1,224 | 1,232 | -25 | -2% | 172,400 |
| 2021/12/09 | 1,286 | 1,288 | 1,257 | 1,257 | -18 | -1.4% | 133,100 |
| 2021/12/08 | 1,295 | 1,300 | 1,261 | 1,275 | -1 | -0.1% | 230,500 |
| 2021/12/07 | 1,246 | 1,278 | 1,239 | 1,276 | +58 | +4.8% | 254,000 |
| 2021/12/06 | 1,271 | 1,271 | 1,213 | 1,218 | -79 | -6.1% | 405,900 |
| 2021/12/03 | 1,275 | 1,297 | 1,258 | 1,297 | +43 | +3.4% | 257,300 |
| 2021/12/02 | 1,273 | 1,286 | 1,251 | 1,254 | -31 | -2.4% | 267,100 |
| 2021/12/01 | 1,326 | 1,350 | 1,277 | 1,285 | -41 | -3.1% | 279,300 |
| 2021/11/30 | 1,342 | 1,367 | 1,321 | 1,326 | +14 | +1.1% | 286,800 |
| 2021/11/29 | 1,340 | 1,389 | 1,308 | 1,312 | -16 | -1.2% | 517,600 |
| 2021/11/26 | 1,374 | 1,383 | 1,320 | 1,328 | -60 | -4.3% | 500,500 |
| 2021/11/25 | 1,412 | 1,423 | 1,356 | 1,388 | -26 | -1.8% | 508,400 |
| 2021/11/24 | 1,456 | 1,467 | 1,384 | 1,414 | -60 | -4.1% | 599,400 |
| 2021/11/22 | 1,464 | 1,477 | 1,430 | 1,474 | -5 | -0.3% | 337,000 |
| 2021/11/19 | 1,546 | 1,562 | 1,469 | 1,479 | -85 | -5.4% | 594,000 |
| 2021/11/18 | 1,570 | 1,588 | 1,547 | 1,564 | -29 | -1.8% | 273,500 |
| 2021/11/17 | 1,563 | 1,631 | 1,537 | 1,593 | +12 | +0.8% | 289,800 |
| 2021/11/16 | 1,627 | 1,640 | 1,541 | 1,581 | -45 | -2.8% | 342,100 |
| 2021/11/15 | 1,597 | 1,657 | 1,501 | 1,626 | -45 | -2.7% | 650,100 |
| 2021/11/12 | 1,629 | 1,679 | 1,625 | 1,671 | +56 | +3.5% | 146,900 |
| 2021/11/11 | 1,656 | 1,658 | 1,614 | 1,615 | -44 | -2.7% | 206,200 |
| 2021/11/10 | 1,658 | 1,695 | 1,650 | 1,659 | -6 | -0.4% | 89,800 |
| 2021/11/09 | 1,689 | 1,712 | 1,660 | 1,665 | -27 | -1.6% | 98,300 |
| 2021/11/08 | 1,729 | 1,729 | 1,650 | 1,692 | -7 | -0.4% | 258,600 |
| 2021/11/05 | 1,723 | 1,752 | 1,693 | 1,699 | -21 | -1.2% | 73,600 |
| 2021/11/04 | 1,791 | 1,807 | 1,704 | 1,720 | +3 | +0.2% | 183,200 |
| 2021/11/02 | 1,741 | 1,769 | 1,715 | 1,717 | -20 | -1.2% | 65,800 |
701～
750
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
